J&J allegedly mismanaged the company's prescription-drug benefits program, according to a lawsuit filed by an employee.

There are many benefits to offering HSAs. But there are also some responsibilities that employers should be aware of.

Placing thoughts in reverse forces advisers to consider avoiding failure to highlight their best paths toward client success.

ERISA preemption faces new questions as more states enact new mandated benefits and assert regulatory authority over certain benefits.

Employee benefit brokers are well-positioned to provide ongoing value to their employer clients well beyond the annual open-enrollment period.

Tailoring genetic information, environment and lifestyle factors to disease treatment and prevention holds incredible promise.

A multipronged effort should include documenting damage, hiring licensed and bonded contractors, and organizing client contact information.

Roughly $1.6 trillion in savings would be preserved in the U.S. retirement system over 40 years if auto portability were adopted nationwide.

Big pharma has been hungry for ways to replace blockbusters that are losing steam, as patents face expiration dates.

Alternative "leagues" that leverage bad rules to a competitive advantage at the expense of others must be eliminated.

The drugmaker's new platform connects patients with doctors who can prescribe medications and provide home delivery of certain drugs.

Fixed medical indemnity plans represent an affordable option for low-wage and part-time employees.

Data shows that the $5,000 annual tax limit does not cover the average price of one child in center-based infant care.

When pharmacists can collaborate with a patient's care team, health outcomes will improve while money and lives are saved.

In the wake of a hastily drafted law that leaves plan sponsors with questions, the goal is to be "as compliant as possible."

The nation's largest hospital system has been cited for failing to make prices fully available to the public

A new rule will allow long-term, part-time employees to contribute to retirement plans by 2025.

This type of drug activates anti-inflammatory pathways in the brain with far-reaching effects that may independently keep the heart healthy.

Initiatives must transcend oversimplified narratives and work toward creating environments where all voices are acknowledged and valued.

FSA account holders may be able to roll up to $610 in unused funds to 2024.